Safety of parenteral anticoagulation as a bridge to warfarin in patients undergoing mechanical aortic valve replacement
The use of therapeutic parenteral anticoagulation with warfarin after mAVR significantly increased the rate of major bleeding compared to warfarin monotherapy. Larger prospective studies are needed to confirm these findings.
Authors
- Bryan A. Whitson (ORCID: https://orcid.org/0000-0003-0040-3638)
- Eric McLaughlin (ORCID: https://orcid.org/0000-0003-2200-5905)
- Alan Rozycki
- Lovepreet Mann
- Laura Andino
Institutions
- The Ohio State University Wexner Medical Center (US)
- The Ohio State University (US)
Publication Details
- Journal
- JTCVS Open
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1016/j.xjon.2025.09.020
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00